IL6 and Fabry disease: Furthermore, the elevated levels of TNF-a, IL-1β, and IL-6 in the serum of FD patients can stimulate mast cells in the gastric mucosa, causing impaired gastrointestinal motility and visceral sensation (Gwee, 2010).